J David Spence George K Dresser
10.1161/JAHA.115.002497
J Am Heart Assoc
2016 Jan 27;5(1):e002497.
persistence adverse effects mitochondrial function statins ubiquinone
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/26819251/
Cardiovascular Diseases / prevention & control Diabetes Mellitus / chemically induced Dyslipidemias / drug therapy Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects Insulin Resistance Lipids / blood Muscular Diseases / chemically induced
Cardiovascular Diseases / prevention & control Diabetes Mellitus / chemically induced Dyslipidemias / drug therapy Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects Insulin Resistance Lipids / blood Muscular Diseases / chemically induced Case Reports Review Biomarkers / blood Cardiovascular Diseases / blood Cardiovascular Diseases / etiology Drug Interactions Drug Substitution Dyslipidemias / blood Dyslipidemias / complications Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacokinetics Male Medication Adherence Middle Aged Pharmacogenetics Practice Patterns, Physicians' Risk Factors Treatment Outcome Biomarkers Hydroxymethylglutaryl-CoA Reductase Inhibitors Lipids
PMC4859367
26819251
Overcoming Challenges With Statin Therapy
2016